What Happened To 23andMe?

23andMe was one of the hottest startups of the 2000s, once valued at $6 billion. The company’s DNA test kits became a viral sensation and powerful research tool for those hoping to learn more about their ancestry and health. But today, it has lost 98% of its value and is on the verge of being delisted from the Nasdaq after all independent board members resigned, citing frustration with founder Anne Wojcicki’s “strategic differences” in her vision for the company. Meanwhile, 23andMe is sitting on the world’s largest genetic database that it once hoped to leverage for drug development. So what will happen to all that DNA data, and can Wojcicki save the company from collapse by taking it private? Watch the video to find out more. Chapters: 00:41 – The early days 04:31 – Going public Produced by: Merritt Enright Edited by: Nora Rappaport Supervising Producer: Jeniece Pettitt Animation: Christina Locopo, Jason Reginato Additional Footage: 23andMe, Getty Images » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more. Want to be a successful, confident communicator? Take CNBC’s online course Become an Effective Communicator: Master Public Speaking. We’ll teach you how to speak clearly and confidently, calm your nerves, what to say and not say, and body language techniques to make a great first impression. Get started today: https://cnb.cx/4aryNgM Connect with CNBC News Online Get the latest news: https://www.cnbc.com/ Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC Follow CNBC on Threads: https://cnb.cx/threads Follow CNBC News on X: https://cnb.cx/FollowCNBC Follow CNBC on WhatsApp: https://cnb.cx/WhatsAppCNBC #CNBC What Happened To 23andMe?